Takaoka K, Yoshikawa H, Shimizu N, Ono K, Amitani K, Nakata Y
Clin Orthop Relat Res. 1982 Apr(164):265-70.
Bone-inducing substance from a murine osteosarcoma (BFO osteosarcoma) was partially purified by biochemical procedures, i.e., extraction by 4M Gu-HCl, fractionation by ethanol, precipitation in neutral buffer solution with low ionic strength and two steps of gel filtration. The yield of the final preparation was 2 mg from 10 g (wet weight) of BFO osteosarcoma. The preparation constantly induced ectopic bone in situ when implanted into allogenic mice. SDS polyacrylamide electrophoresis revealed that the biologically active fraction contained two distinct substances, the molecular weights of which were 19,500 and 22,500, respectively. Further purification of the bone-inducing substance is now in progress.
通过生化方法对来自小鼠骨肉瘤(BFO骨肉瘤)的骨诱导物质进行了部分纯化,即采用4M盐酸胍提取、乙醇分级分离、在低离子强度的中性缓冲溶液中沉淀以及两步凝胶过滤。最终制剂的产量为从10克(湿重)BFO骨肉瘤中获得2毫克。该制剂植入同种异体小鼠体内时能持续原位诱导异位骨形成。十二烷基硫酸钠-聚丙烯酰胺凝胶电泳显示,生物活性部分含有两种不同的物质,其分子量分别为19,500和22,500。目前正在对骨诱导物质进行进一步纯化。